Education
About Us
Working with TipRanks
Follow Us
Proteonomix Inc (PROT)
OTHER OTC:PROT
PROT Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume4.60K
Average Volume (3M)0.00
Market Cap
$23.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta12.78
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,812,859
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PROT FAQ
What was Proteonomix Inc’s price range in the past 12 months?
Proteonomix Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Proteonomix Inc’s market cap?
Proteonomix Inc’s market cap is $23.00.
When is Proteonomix Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Proteonomix Inc’s earnings last quarter?
Currently, no data Available
Is Proteonomix Inc overvalued?
According to Wall Street analysts Proteonomix Inc’s price is currently Overvalued.
Does Proteonomix Inc pay dividends?
Proteonomix Inc does not currently pay dividends.
What is Proteonomix Inc’s EPS estimate?
Proteonomix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Proteonomix Inc have?
Proteonomix Inc has 22,812,859 shares outstanding.
What happened to Proteonomix Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Proteonomix Inc?
Currently, no hedge funds are holding shares in PROT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Proteonomix Inc
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.